BDTX - Black Diamond Therapeutics Inc
2.27
0.090 3.965%
Share volume: 805,365
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.18
0.09
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-05-2024 | 03-06-2025 | 05-12-2025 | 11-06-2025 | |
| Assets | |||||||
| Total Assets | 142.521 M | 149.986 M | 137.896 M | 122.640 M | 176.245 M | 157.733 M | |
| Current Assets | 118.806 M | 126.754 M | 115.538 M | 101.176 M | 155.679 M | 138.992 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 89.777 M | 90.160 M | 89.257 M | 62.138 M | 53.976 M | 104.639 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 25.422 M | 32.811 M | 23.425 M | 36.437 M | 98.424 M | 30.864 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.644 M | 1.558 M | 1.472 M | 1.387 M | 1.300 M | 1.128 M | |
| Other Assets | 22.071 M | 21.674 M | 20.886 M | 20.077 M | 19.266 M | 17.613 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 142.521 M | 149.986 M | 137.896 M | 122.640 M | 176.245 M | 157.733 M | |
| Total liabilities | 38.215 M | 38.965 M | 40.470 M | 39.355 M | 34.729 M | 31.581 M | |
| Total current liabilities | 16.854 M | 18.439 M | 20.800 M | 20.573 M | 16.847 M | 15.545 M | |
| Accounts Payable | 1.176 M | 763.000 K | 1.971 M | 4.007 M | 2.628 M | 975.000 K | |
| Other liabilities | 21.361 M | 20.526 M | 19.670 M | 18.782 M | 17.882 M | 16.036 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 21.361 M | 20.526 M | 19.670 M | 18.782 M | 17.882 M | 16.036 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 104.306 M | 111.021 M | 97.426 M | 83.285 M | 141.516 M | 126.152 M | |
| Common stock | 540.057 M | 566.701 M | 568.441 M | 570.368 M | 572.100 M | 575.634 M | |
| Retained earnings | -435.656 M | -455.565 M | -471.122 M | -487.107 M | -430.565 M | -449.624 M |